Ethics of placebos in clinical asthma trials [5]

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 2, 2006, Pages 470-

  Coffey, M Justin ^a   Ross, Lainie Friedman ^b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PLACEBO;

ASTHMA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; PRIORITY JOURNAL; RISK; TREATMENT RESPONSE;

ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS; ETHICS, MEDICAL; HUMANS; PLACEBOS; RISK ASSESSMENT;

EID: 31944440955     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.09.014     Document Type: Letter

References (4)

1. R.F. Onder The ethics of placebo-controlled trials: the case of asthma J Allergy Clin Immunol 115 2005 1228 1234
2. Declaration of Helsinki: ethical principles for medical research involving human subjects. Note of clarification on paragraph 29 added by the World Medical Association General Assembly. Washington, DC: World Medical Association; 2002. [Cited 2005 October 18]. Available at: http://www.wma.net/e/ policy/b3.htm
3. National Heart, Lung, & Blood Institute, U.S. Department of Health and Human Services, World Health Organization. Asthma Management and Prevention: A Practical Guide for Public Health Officials and Health Care Professionals, Based on the Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop Report. Bethesda (Md): NIH Publication No. 96-3659A; 1995.
4. M.J. Coffey, B. Wilfond, and L.F. Ross Ethical assessment of clinical asthma trials including children subjects Pediatrics 133 2004 87 94